Alterations in glutathione S-transferase pi expression following exposure to MPP +-induced oxidative stress in the blood of Parkinson's disease patients

Ane Korff, Brenda Pfeiffer, Michelle Smeyne, Mehmet Kocak, Ronald F. Pfeiffer, Richard Jay Smeyne

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The major motor symptoms of Parkinson's disease do not occur until a majority of the dopaminergic neurons in the midbrain SNpc have already died. For this reason, it is critical to identify biomarkers that will allow for the identification of presymptomatic individuals. In this study, we examine the baseline expression of the anti-oxidant protein glutathione S-transferase pi (GSTpi) in the blood of PD patients and environmentally- and age-matched controls and compare it to GSTpi levels following exposure to 1-methyl-4-phenylpyridinium (MPP +), an agent that has been shown to induce oxidative stress. We find that after 4 h of exposure to MPP +, significant increases in GSTpi levels can be observed in the leukocytes of PD patients. No changes were seen in other blood components. This suggests that GSTpi and potentially other members of this and other anti-oxidant families may be viable biomarkers for PD.

Original languageEnglish (US)
Pages (from-to)765-768
Number of pages4
JournalParkinsonism and Related Disorders
Volume17
Issue number10
DOIs
StatePublished - Dec 1 2011

Fingerprint

Glutathione S-Transferase pi
Hematologic Diseases
Parkinson Disease
Oxidative Stress
Oxidants
Biomarkers
1-Methyl-4-phenylpyridinium
Dopaminergic Neurons
Protein S
Mesencephalon
Leukocytes

All Science Journal Classification (ASJC) codes

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Cite this

Alterations in glutathione S-transferase pi expression following exposure to MPP +-induced oxidative stress in the blood of Parkinson's disease patients. / Korff, Ane; Pfeiffer, Brenda; Smeyne, Michelle; Kocak, Mehmet; Pfeiffer, Ronald F.; Smeyne, Richard Jay.

In: Parkinsonism and Related Disorders, Vol. 17, No. 10, 01.12.2011, p. 765-768.

Research output: Contribution to journalArticle

Korff, Ane ; Pfeiffer, Brenda ; Smeyne, Michelle ; Kocak, Mehmet ; Pfeiffer, Ronald F. ; Smeyne, Richard Jay. / Alterations in glutathione S-transferase pi expression following exposure to MPP +-induced oxidative stress in the blood of Parkinson's disease patients. In: Parkinsonism and Related Disorders. 2011 ; Vol. 17, No. 10. pp. 765-768.
@article{b2aa2a2ba7894725b8e00ec2cc4c2bbc,
title = "Alterations in glutathione S-transferase pi expression following exposure to MPP +-induced oxidative stress in the blood of Parkinson's disease patients",
abstract = "The major motor symptoms of Parkinson's disease do not occur until a majority of the dopaminergic neurons in the midbrain SNpc have already died. For this reason, it is critical to identify biomarkers that will allow for the identification of presymptomatic individuals. In this study, we examine the baseline expression of the anti-oxidant protein glutathione S-transferase pi (GSTpi) in the blood of PD patients and environmentally- and age-matched controls and compare it to GSTpi levels following exposure to 1-methyl-4-phenylpyridinium (MPP +), an agent that has been shown to induce oxidative stress. We find that after 4 h of exposure to MPP +, significant increases in GSTpi levels can be observed in the leukocytes of PD patients. No changes were seen in other blood components. This suggests that GSTpi and potentially other members of this and other anti-oxidant families may be viable biomarkers for PD.",
author = "Ane Korff and Brenda Pfeiffer and Michelle Smeyne and Mehmet Kocak and Pfeiffer, {Ronald F.} and Smeyne, {Richard Jay}",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.parkreldis.2011.06.026",
language = "English (US)",
volume = "17",
pages = "765--768",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "10",

}

TY - JOUR

T1 - Alterations in glutathione S-transferase pi expression following exposure to MPP +-induced oxidative stress in the blood of Parkinson's disease patients

AU - Korff, Ane

AU - Pfeiffer, Brenda

AU - Smeyne, Michelle

AU - Kocak, Mehmet

AU - Pfeiffer, Ronald F.

AU - Smeyne, Richard Jay

PY - 2011/12/1

Y1 - 2011/12/1

N2 - The major motor symptoms of Parkinson's disease do not occur until a majority of the dopaminergic neurons in the midbrain SNpc have already died. For this reason, it is critical to identify biomarkers that will allow for the identification of presymptomatic individuals. In this study, we examine the baseline expression of the anti-oxidant protein glutathione S-transferase pi (GSTpi) in the blood of PD patients and environmentally- and age-matched controls and compare it to GSTpi levels following exposure to 1-methyl-4-phenylpyridinium (MPP +), an agent that has been shown to induce oxidative stress. We find that after 4 h of exposure to MPP +, significant increases in GSTpi levels can be observed in the leukocytes of PD patients. No changes were seen in other blood components. This suggests that GSTpi and potentially other members of this and other anti-oxidant families may be viable biomarkers for PD.

AB - The major motor symptoms of Parkinson's disease do not occur until a majority of the dopaminergic neurons in the midbrain SNpc have already died. For this reason, it is critical to identify biomarkers that will allow for the identification of presymptomatic individuals. In this study, we examine the baseline expression of the anti-oxidant protein glutathione S-transferase pi (GSTpi) in the blood of PD patients and environmentally- and age-matched controls and compare it to GSTpi levels following exposure to 1-methyl-4-phenylpyridinium (MPP +), an agent that has been shown to induce oxidative stress. We find that after 4 h of exposure to MPP +, significant increases in GSTpi levels can be observed in the leukocytes of PD patients. No changes were seen in other blood components. This suggests that GSTpi and potentially other members of this and other anti-oxidant families may be viable biomarkers for PD.

UR - http://www.scopus.com/inward/record.url?scp=81155162501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81155162501&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2011.06.026

DO - 10.1016/j.parkreldis.2011.06.026

M3 - Article

VL - 17

SP - 765

EP - 768

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 10

ER -